Difference between revisions of "Myotonic muscular dystrophy"

From WikiAnesthesia
(Created page with "{{Infobox comorbidity | other_names = | image = | caption = | anesthetic_relevance = | specialty = | signs_symptoms = | diagnosis = | treatment = }}Provide a brief summary of this comorbidity here. ==Anesthetic implications<!-- Briefly summarize the anesthetic implications of this comorbidity. -->== ===Preoperative optimization<!-- Describe how this comorbidity may influence preoperative evaluation and optimization of patients. -->=== ===Intraoperative managem...")
 
 
Line 3: Line 3:
| image =  
| image =  
| caption =  
| caption =  
| anesthetic_relevance =  
| anesthetic_relevance = High
| specialty =  
| anesthetic_management = Induce with RSI with roc and reverse with sugammadex. Sux, roc, and neostigmine may produce atypical responses.
| specialty = MSK
| signs_symptoms =  
| signs_symptoms =  
| diagnosis =  
| diagnosis =  
| treatment =  
| treatment =  
}}Provide a brief summary of this comorbidity here.
}}
 
 
There are two types of myotonic dystrophy caused by two mutations in two distinct gene loci: myotonic dystrophy types 1 and 2. Type 1 is a multisystem disease affecting the musculoskeletal system, the heart, the respiratory system, the central nervous system and the endocrine system. Type 2 has similar manifestations, but is less severe.
 
Muscle weakness begins distally and progresses proximally, with muscle wasting developing over time.  


==Anesthetic implications<!-- Briefly summarize the anesthetic implications of this comorbidity. -->==
==Anesthetic implications<!-- Briefly summarize the anesthetic implications of this comorbidity. -->==
Line 15: Line 21:


===Intraoperative management<!-- Describe how this comorbidity may influence intraoperative management. -->===
===Intraoperative management<!-- Describe how this comorbidity may influence intraoperative management. -->===
Succinylcholine produces exaggerated contractures severe enough to impair ventilation, and can make intubation/ventilation very difficult. May have enhanced response to NDNMBs due to chronic myopathy. Neostigmine may provoke myotonia. Peripheral nerve stimulators may provoke myotonia.
The generally preferred option for induction is RSI with rocuronium and eventual reversal with sugammadex.


===Postoperative management<!-- Describe how this comorbidity may influence postoperative management. -->===
===Postoperative management<!-- Describe how this comorbidity may influence postoperative management. -->===
Line 21: Line 30:


==Pathophysiology<!-- Describe the pathophysiology of this comorbidity. Add subsections as needed. -->==
==Pathophysiology<!-- Describe the pathophysiology of this comorbidity. Add subsections as needed. -->==
Myotonic dystrophy is theorized to be caused by an abnormality in the intracellular adenosine triphosphate system, causing a failure of calcium to return to the sarcoplasmic reticulum and hence a myotonic response (delayed relaxation of skeletal muscle after voluntary contraction).


==Signs and symptoms<!-- Describe the signs and symptoms of this comorbidity. -->==
==Signs and symptoms<!-- Describe the signs and symptoms of this comorbidity. -->==
MSK: Myotonic responses to voluntary movement. 
Respiratory: Pulmonary function test reveals restrictive lung disease pattern due to contractures of intercostal muscles. Ventilatory response to hypoxia and hypercarbia is impaired. Patients are predisposed to developing pneumonia due to reduced lung volume and ineffective cough mechanism. Patients are especially sensitive to the respiratory depressant effects of common anesthetic medications
Endocrine: insulin resistance
Cardiac: defects in cardiac conduction
CNS: neuropsychiatric impairment
HEENT: Cataracts, frontal balding in males
GU: Testicular atrophy.
Gyn: High incidence of OB complications including polyhydramnios, breech, premature labor, impaired cervical dilation, uterine atony, retained placenta, postpartum hemorrhage. Symptoms are exacerbated by pregnancy due to elevated progesterone levels.


==Diagnosis<!-- Describe how this comorbidity is diagnosed. -->==
==Diagnosis<!-- Describe how this comorbidity is diagnosed. -->==

Latest revision as of 03:02, 22 July 2022

Myotonic muscular dystrophy
Anesthetic relevance

High

Anesthetic management

Induce with RSI with roc and reverse with sugammadex. Sux, roc, and neostigmine may produce atypical responses.

Specialty

MSK

Signs and symptoms
Diagnosis
Treatment
Article quality
Editor rating
Unrated
User likes
0


There are two types of myotonic dystrophy caused by two mutations in two distinct gene loci: myotonic dystrophy types 1 and 2. Type 1 is a multisystem disease affecting the musculoskeletal system, the heart, the respiratory system, the central nervous system and the endocrine system. Type 2 has similar manifestations, but is less severe.

Muscle weakness begins distally and progresses proximally, with muscle wasting developing over time.

Anesthetic implications

Preoperative optimization

Intraoperative management

Succinylcholine produces exaggerated contractures severe enough to impair ventilation, and can make intubation/ventilation very difficult. May have enhanced response to NDNMBs due to chronic myopathy. Neostigmine may provoke myotonia. Peripheral nerve stimulators may provoke myotonia.

The generally preferred option for induction is RSI with rocuronium and eventual reversal with sugammadex.

Postoperative management

Related surgical procedures

Pathophysiology

Myotonic dystrophy is theorized to be caused by an abnormality in the intracellular adenosine triphosphate system, causing a failure of calcium to return to the sarcoplasmic reticulum and hence a myotonic response (delayed relaxation of skeletal muscle after voluntary contraction).

Signs and symptoms

MSK: Myotonic responses to voluntary movement.

Respiratory: Pulmonary function test reveals restrictive lung disease pattern due to contractures of intercostal muscles. Ventilatory response to hypoxia and hypercarbia is impaired. Patients are predisposed to developing pneumonia due to reduced lung volume and ineffective cough mechanism. Patients are especially sensitive to the respiratory depressant effects of common anesthetic medications

Endocrine: insulin resistance

Cardiac: defects in cardiac conduction

CNS: neuropsychiatric impairment

HEENT: Cataracts, frontal balding in males

GU: Testicular atrophy.

Gyn: High incidence of OB complications including polyhydramnios, breech, premature labor, impaired cervical dilation, uterine atony, retained placenta, postpartum hemorrhage. Symptoms are exacerbated by pregnancy due to elevated progesterone levels.

Diagnosis

Treatment

Medication

Surgery

Prognosis

Epidemiology

References